nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Niclosamide—STAT3—ovarian cancer	0.0254	0.773	CrCbGaD
Tolcapone—Tolmetin—CXCL8—ovarian cancer	0.00745	0.227	CrCbGaD
Tolcapone—COMT—myometrium—ovarian cancer	0.00681	0.128	CbGeAlD
Tolcapone—COMT—uterine cervix—ovarian cancer	0.0053	0.0993	CbGeAlD
Tolcapone—COMT—decidua—ovarian cancer	0.00505	0.0946	CbGeAlD
Tolcapone—COMT—endometrium—ovarian cancer	0.00479	0.0898	CbGeAlD
Tolcapone—COMT—gonad—ovarian cancer	0.00444	0.0833	CbGeAlD
Tolcapone—COMT—uterus—ovarian cancer	0.00442	0.0828	CbGeAlD
Tolcapone—COMT—female reproductive system—ovarian cancer	0.00397	0.0744	CbGeAlD
Tolcapone—COMT—bone marrow—ovarian cancer	0.00375	0.0703	CbGeAlD
Tolcapone—COMT—female gonad—ovarian cancer	0.00361	0.0677	CbGeAlD
Tolcapone—COMT—vagina—ovarian cancer	0.00359	0.0673	CbGeAlD
Tolcapone—COMT—testis—ovarian cancer	0.0032	0.0601	CbGeAlD
Tolcapone—COMT—lymph node—ovarian cancer	0.00232	0.0435	CbGeAlD
Tolcapone—CYP2C9—female reproductive system—ovarian cancer	0.00209	0.0391	CbGeAlD
Tolcapone—Dysphagia—Doxorubicin—ovarian cancer	0.000576	0.000631	CcSEcCtD
Tolcapone—Pollakiuria—Epirubicin—ovarian cancer	0.000575	0.00063	CcSEcCtD
Tolcapone—Palpitations—Docetaxel—ovarian cancer	0.000569	0.000622	CcSEcCtD
Tolcapone—Loss of consciousness—Docetaxel—ovarian cancer	0.000565	0.000619	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000564	0.000618	CcSEcCtD
Tolcapone—Weight decreased—Epirubicin—ovarian cancer	0.000563	0.000617	CcSEcCtD
Tolcapone—Cough—Docetaxel—ovarian cancer	0.000561	0.000614	CcSEcCtD
Tolcapone—Angina pectoris—Doxorubicin—ovarian cancer	0.000561	0.000614	CcSEcCtD
Tolcapone—Pneumonia—Epirubicin—ovarian cancer	0.000559	0.000611	CcSEcCtD
Tolcapone—Paraesthesia—Paclitaxel—ovarian cancer	0.000556	0.000609	CcSEcCtD
Tolcapone—Hypertension—Docetaxel—ovarian cancer	0.000555	0.000608	CcSEcCtD
Tolcapone—Infestation—Epirubicin—ovarian cancer	0.000555	0.000608	CcSEcCtD
Tolcapone—Infestation NOS—Epirubicin—ovarian cancer	0.000555	0.000608	CcSEcCtD
Tolcapone—Bronchitis—Doxorubicin—ovarian cancer	0.000554	0.000606	CcSEcCtD
Tolcapone—Dyspnoea—Paclitaxel—ovarian cancer	0.000552	0.000604	CcSEcCtD
Tolcapone—Somnolence—Paclitaxel—ovarian cancer	0.000551	0.000603	CcSEcCtD
Tolcapone—Myalgia—Docetaxel—ovarian cancer	0.000548	0.000599	CcSEcCtD
Tolcapone—Arthralgia—Docetaxel—ovarian cancer	0.000548	0.000599	CcSEcCtD
Tolcapone—Chest pain—Docetaxel—ovarian cancer	0.000548	0.000599	CcSEcCtD
Tolcapone—Nausea—Vinorelbine—ovarian cancer	0.000547	0.000599	CcSEcCtD
Tolcapone—Dyspepsia—Paclitaxel—ovarian cancer	0.000545	0.000597	CcSEcCtD
Tolcapone—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000544	0.000596	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000544	0.000595	CcSEcCtD
Tolcapone—Stomatitis—Epirubicin—ovarian cancer	0.000541	0.000592	CcSEcCtD
Tolcapone—Urinary tract infection—Epirubicin—ovarian cancer	0.00054	0.000591	CcSEcCtD
Tolcapone—Dysuria—Doxorubicin—ovarian cancer	0.000539	0.00059	CcSEcCtD
Tolcapone—Decreased appetite—Paclitaxel—ovarian cancer	0.000539	0.000589	CcSEcCtD
Tolcapone—Dry mouth—Docetaxel—ovarian cancer	0.000536	0.000586	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000536	0.000586	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000535	0.000585	CcSEcCtD
Tolcapone—Fatigue—Paclitaxel—ovarian cancer	0.000534	0.000584	CcSEcCtD
Tolcapone—Sweating—Epirubicin—ovarian cancer	0.000532	0.000583	CcSEcCtD
Tolcapone—Pollakiuria—Doxorubicin—ovarian cancer	0.000532	0.000583	CcSEcCtD
Tolcapone—Pain—Paclitaxel—ovarian cancer	0.00053	0.00058	CcSEcCtD
Tolcapone—Constipation—Paclitaxel—ovarian cancer	0.00053	0.00058	CcSEcCtD
Tolcapone—Haematuria—Epirubicin—ovarian cancer	0.000529	0.000579	CcSEcCtD
Tolcapone—Confusional state—Docetaxel—ovarian cancer	0.000529	0.000579	CcSEcCtD
Tolcapone—Oedema—Docetaxel—ovarian cancer	0.000525	0.000575	CcSEcCtD
Tolcapone—Epistaxis—Epirubicin—ovarian cancer	0.000524	0.000573	CcSEcCtD
Tolcapone—Infection—Docetaxel—ovarian cancer	0.000522	0.000571	CcSEcCtD
Tolcapone—Weight decreased—Doxorubicin—ovarian cancer	0.000521	0.000571	CcSEcCtD
Tolcapone—Sinusitis—Epirubicin—ovarian cancer	0.000521	0.00057	CcSEcCtD
Tolcapone—Pneumonia—Doxorubicin—ovarian cancer	0.000517	0.000566	CcSEcCtD
Tolcapone—Shock—Docetaxel—ovarian cancer	0.000517	0.000565	CcSEcCtD
Tolcapone—Nervous system disorder—Docetaxel—ovarian cancer	0.000515	0.000564	CcSEcCtD
Tolcapone—Thrombocytopenia—Docetaxel—ovarian cancer	0.000514	0.000563	CcSEcCtD
Tolcapone—Infestation NOS—Doxorubicin—ovarian cancer	0.000514	0.000562	CcSEcCtD
Tolcapone—Infestation—Doxorubicin—ovarian cancer	0.000514	0.000562	CcSEcCtD
Tolcapone—Tachycardia—Docetaxel—ovarian cancer	0.000512	0.000561	CcSEcCtD
Tolcapone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000511	0.000559	CcSEcCtD
Tolcapone—Skin disorder—Docetaxel—ovarian cancer	0.00051	0.000558	CcSEcCtD
Tolcapone—Bradycardia—Epirubicin—ovarian cancer	0.000508	0.000555	CcSEcCtD
Tolcapone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000507	0.000554	CcSEcCtD
Tolcapone—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000504	0.000551	CcSEcCtD
Tolcapone—Haemoglobin—Epirubicin—ovarian cancer	0.000501	0.000548	CcSEcCtD
Tolcapone—Stomatitis—Doxorubicin—ovarian cancer	0.000501	0.000548	CcSEcCtD
Tolcapone—Anorexia—Docetaxel—ovarian cancer	0.000501	0.000548	CcSEcCtD
Tolcapone—Rhinitis—Epirubicin—ovarian cancer	0.0005	0.000547	CcSEcCtD
Tolcapone—Urinary tract infection—Doxorubicin—ovarian cancer	0.000499	0.000547	CcSEcCtD
Tolcapone—Haemorrhage—Epirubicin—ovarian cancer	0.000499	0.000546	CcSEcCtD
Tolcapone—Hypoaesthesia—Epirubicin—ovarian cancer	0.000496	0.000543	CcSEcCtD
Tolcapone—Pharyngitis—Epirubicin—ovarian cancer	0.000495	0.000541	CcSEcCtD
Tolcapone—Sweating—Doxorubicin—ovarian cancer	0.000493	0.000539	CcSEcCtD
Tolcapone—Urinary tract disorder—Epirubicin—ovarian cancer	0.000492	0.000539	CcSEcCtD
Tolcapone—Urticaria—Paclitaxel—ovarian cancer	0.000492	0.000539	CcSEcCtD
Tolcapone—Oedema peripheral—Epirubicin—ovarian cancer	0.000491	0.000537	CcSEcCtD
Tolcapone—Hypotension—Docetaxel—ovarian cancer	0.000491	0.000537	CcSEcCtD
Tolcapone—Haematuria—Doxorubicin—ovarian cancer	0.00049	0.000536	CcSEcCtD
Tolcapone—Abdominal pain—Paclitaxel—ovarian cancer	0.00049	0.000536	CcSEcCtD
Tolcapone—Body temperature increased—Paclitaxel—ovarian cancer	0.00049	0.000536	CcSEcCtD
Tolcapone—Urethral disorder—Epirubicin—ovarian cancer	0.000489	0.000535	CcSEcCtD
Tolcapone—Epistaxis—Doxorubicin—ovarian cancer	0.000485	0.00053	CcSEcCtD
Tolcapone—Sinusitis—Doxorubicin—ovarian cancer	0.000482	0.000528	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000478	0.000524	CcSEcCtD
Tolcapone—Paraesthesia—Docetaxel—ovarian cancer	0.000472	0.000516	CcSEcCtD
Tolcapone—Erythema multiforme—Epirubicin—ovarian cancer	0.000471	0.000516	CcSEcCtD
Tolcapone—Bradycardia—Doxorubicin—ovarian cancer	0.00047	0.000514	CcSEcCtD
Tolcapone—Dyspnoea—Docetaxel—ovarian cancer	0.000468	0.000512	CcSEcCtD
Tolcapone—Somnolence—Docetaxel—ovarian cancer	0.000467	0.000511	CcSEcCtD
Tolcapone—Tinnitus—Epirubicin—ovarian cancer	0.000465	0.000509	CcSEcCtD
Tolcapone—Haemoglobin—Doxorubicin—ovarian cancer	0.000464	0.000507	CcSEcCtD
Tolcapone—Rhinitis—Doxorubicin—ovarian cancer	0.000462	0.000506	CcSEcCtD
Tolcapone—Dyspepsia—Docetaxel—ovarian cancer	0.000462	0.000506	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—ovarian cancer	0.000461	0.000505	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000459	0.000502	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—ovarian cancer	0.000458	0.000501	CcSEcCtD
Tolcapone—Decreased appetite—Docetaxel—ovarian cancer	0.000456	0.0005	CcSEcCtD
Tolcapone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000456	0.000499	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000456	0.000498	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—ovarian cancer	0.000454	0.000497	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000453	0.000496	CcSEcCtD
Tolcapone—Fatigue—Docetaxel—ovarian cancer	0.000453	0.000495	CcSEcCtD
Tolcapone—Angiopathy—Epirubicin—ovarian cancer	0.000452	0.000495	CcSEcCtD
Tolcapone—Urethral disorder—Doxorubicin—ovarian cancer	0.000452	0.000495	CcSEcCtD
Tolcapone—Mediastinal disorder—Epirubicin—ovarian cancer	0.000449	0.000492	CcSEcCtD
Tolcapone—Pain—Docetaxel—ovarian cancer	0.000449	0.000491	CcSEcCtD
Tolcapone—Constipation—Docetaxel—ovarian cancer	0.000449	0.000491	CcSEcCtD
Tolcapone—Chills—Epirubicin—ovarian cancer	0.000447	0.000489	CcSEcCtD
Tolcapone—Arrhythmia—Epirubicin—ovarian cancer	0.000445	0.000487	CcSEcCtD
Tolcapone—Asthenia—Paclitaxel—ovarian cancer	0.000444	0.000486	CcSEcCtD
Tolcapone—Alopecia—Epirubicin—ovarian cancer	0.000441	0.000482	CcSEcCtD
Tolcapone—Pruritus—Paclitaxel—ovarian cancer	0.000438	0.00048	CcSEcCtD
Tolcapone—Mental disorder—Epirubicin—ovarian cancer	0.000437	0.000478	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—ovarian cancer	0.000436	0.000477	CcSEcCtD
Tolcapone—Feeling abnormal—Docetaxel—ovarian cancer	0.000433	0.000474	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—ovarian cancer	0.00043	0.000471	CcSEcCtD
Tolcapone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000429	0.00047	CcSEcCtD
Tolcapone—Flatulence—Epirubicin—ovarian cancer	0.000428	0.000468	CcSEcCtD
Tolcapone—Tension—Epirubicin—ovarian cancer	0.000426	0.000466	CcSEcCtD
Tolcapone—Dysgeusia—Epirubicin—ovarian cancer	0.000425	0.000465	CcSEcCtD
Tolcapone—Diarrhoea—Paclitaxel—ovarian cancer	0.000424	0.000464	CcSEcCtD
Tolcapone—Nervousness—Epirubicin—ovarian cancer	0.000421	0.000461	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—ovarian cancer	0.000418	0.000458	CcSEcCtD
Tolcapone—Muscle spasms—Epirubicin—ovarian cancer	0.000417	0.000457	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000416	0.000455	CcSEcCtD
Tolcapone—Body temperature increased—Docetaxel—ovarian cancer	0.000415	0.000454	CcSEcCtD
Tolcapone—Abdominal pain—Docetaxel—ovarian cancer	0.000415	0.000454	CcSEcCtD
Tolcapone—Chills—Doxorubicin—ovarian cancer	0.000414	0.000453	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—ovarian cancer	0.000412	0.000451	CcSEcCtD
Tolcapone—Dizziness—Paclitaxel—ovarian cancer	0.00041	0.000448	CcSEcCtD
Tolcapone—Vision blurred—Epirubicin—ovarian cancer	0.000409	0.000448	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—ovarian cancer	0.000408	0.000446	CcSEcCtD
Tolcapone—Mental disorder—Doxorubicin—ovarian cancer	0.000404	0.000442	CcSEcCtD
Tolcapone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000403	0.000441	CcSEcCtD
Tolcapone—Anaemia—Epirubicin—ovarian cancer	0.000401	0.000439	CcSEcCtD
Tolcapone—Agitation—Epirubicin—ovarian cancer	0.000399	0.000436	CcSEcCtD
Tolcapone—Flatulence—Doxorubicin—ovarian cancer	0.000396	0.000433	CcSEcCtD
Tolcapone—Tension—Doxorubicin—ovarian cancer	0.000394	0.000431	CcSEcCtD
Tolcapone—Vomiting—Paclitaxel—ovarian cancer	0.000394	0.000431	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—ovarian cancer	0.000393	0.00043	CcSEcCtD
Tolcapone—Malaise—Epirubicin—ovarian cancer	0.000391	0.000428	CcSEcCtD
Tolcapone—Rash—Paclitaxel—ovarian cancer	0.000391	0.000427	CcSEcCtD
Tolcapone—Dermatitis—Paclitaxel—ovarian cancer	0.00039	0.000427	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—ovarian cancer	0.00039	0.000427	CcSEcCtD
Tolcapone—Vertigo—Epirubicin—ovarian cancer	0.00039	0.000427	CcSEcCtD
Tolcapone—Syncope—Epirubicin—ovarian cancer	0.000389	0.000426	CcSEcCtD
Tolcapone—Headache—Paclitaxel—ovarian cancer	0.000388	0.000425	CcSEcCtD
Tolcapone—Hypersensitivity—Docetaxel—ovarian cancer	0.000387	0.000423	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—ovarian cancer	0.000386	0.000422	CcSEcCtD
Tolcapone—Palpitations—Epirubicin—ovarian cancer	0.000383	0.00042	CcSEcCtD
Tolcapone—Loss of consciousness—Epirubicin—ovarian cancer	0.000381	0.000417	CcSEcCtD
Tolcapone—Cough—Epirubicin—ovarian cancer	0.000379	0.000414	CcSEcCtD
Tolcapone—Vision blurred—Doxorubicin—ovarian cancer	0.000378	0.000414	CcSEcCtD
Tolcapone—Asthenia—Docetaxel—ovarian cancer	0.000377	0.000412	CcSEcCtD
Tolcapone—Hypertension—Epirubicin—ovarian cancer	0.000375	0.00041	CcSEcCtD
Tolcapone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000373	0.000408	CcSEcCtD
Tolcapone—Pruritus—Docetaxel—ovarian cancer	0.000372	0.000407	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—ovarian cancer	0.000371	0.000406	CcSEcCtD
Tolcapone—Myalgia—Epirubicin—ovarian cancer	0.000369	0.000404	CcSEcCtD
Tolcapone—Arthralgia—Epirubicin—ovarian cancer	0.000369	0.000404	CcSEcCtD
Tolcapone—Chest pain—Epirubicin—ovarian cancer	0.000369	0.000404	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—ovarian cancer	0.000369	0.000404	CcSEcCtD
Tolcapone—Anxiety—Epirubicin—ovarian cancer	0.000368	0.000403	CcSEcCtD
Tolcapone—Nausea—Paclitaxel—ovarian cancer	0.000368	0.000403	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000367	0.000402	CcSEcCtD
Tolcapone—Discomfort—Epirubicin—ovarian cancer	0.000365	0.000399	CcSEcCtD
Tolcapone—Malaise—Doxorubicin—ovarian cancer	0.000362	0.000396	CcSEcCtD
Tolcapone—Dry mouth—Epirubicin—ovarian cancer	0.000361	0.000395	CcSEcCtD
Tolcapone—Vertigo—Doxorubicin—ovarian cancer	0.000361	0.000395	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—ovarian cancer	0.00036	0.000394	CcSEcCtD
Tolcapone—Diarrhoea—Docetaxel—ovarian cancer	0.000359	0.000393	CcSEcCtD
Tolcapone—Confusional state—Epirubicin—ovarian cancer	0.000357	0.000391	CcSEcCtD
Tolcapone—Palpitations—Doxorubicin—ovarian cancer	0.000355	0.000388	CcSEcCtD
Tolcapone—Oedema—Epirubicin—ovarian cancer	0.000354	0.000388	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—ovarian cancer	0.000353	0.000386	CcSEcCtD
Tolcapone—Infection—Epirubicin—ovarian cancer	0.000352	0.000385	CcSEcCtD
Tolcapone—Cough—Doxorubicin—ovarian cancer	0.00035	0.000383	CcSEcCtD
Tolcapone—Shock—Epirubicin—ovarian cancer	0.000348	0.000381	CcSEcCtD
Tolcapone—Nervous system disorder—Epirubicin—ovarian cancer	0.000347	0.00038	CcSEcCtD
Tolcapone—Dizziness—Docetaxel—ovarian cancer	0.000347	0.00038	CcSEcCtD
Tolcapone—Thrombocytopenia—Epirubicin—ovarian cancer	0.000347	0.000379	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—ovarian cancer	0.000347	0.000379	CcSEcCtD
Tolcapone—Tachycardia—Epirubicin—ovarian cancer	0.000346	0.000378	CcSEcCtD
Tolcapone—Skin disorder—Epirubicin—ovarian cancer	0.000344	0.000376	CcSEcCtD
Tolcapone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000342	0.000375	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—ovarian cancer	0.000342	0.000374	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—ovarian cancer	0.000342	0.000374	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—ovarian cancer	0.000342	0.000374	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—ovarian cancer	0.000341	0.000373	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000339	0.000372	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—ovarian cancer	0.000338	0.00037	CcSEcCtD
Tolcapone—Anorexia—Epirubicin—ovarian cancer	0.000338	0.000369	CcSEcCtD
Tolcapone—Dry mouth—Doxorubicin—ovarian cancer	0.000334	0.000366	CcSEcCtD
Tolcapone—Vomiting—Docetaxel—ovarian cancer	0.000334	0.000365	CcSEcCtD
Tolcapone—Rash—Docetaxel—ovarian cancer	0.000331	0.000362	CcSEcCtD
Tolcapone—Hypotension—Epirubicin—ovarian cancer	0.000331	0.000362	CcSEcCtD
Tolcapone—Dermatitis—Docetaxel—ovarian cancer	0.000331	0.000362	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—ovarian cancer	0.00033	0.000362	CcSEcCtD
Tolcapone—Headache—Docetaxel—ovarian cancer	0.000329	0.00036	CcSEcCtD
Tolcapone—Oedema—Doxorubicin—ovarian cancer	0.000328	0.000359	CcSEcCtD
Tolcapone—Infection—Doxorubicin—ovarian cancer	0.000326	0.000356	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000323	0.000353	CcSEcCtD
Tolcapone—Shock—Doxorubicin—ovarian cancer	0.000322	0.000353	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—ovarian cancer	0.000321	0.000352	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000321	0.000351	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—ovarian cancer	0.00032	0.00035	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—ovarian cancer	0.000318	0.000348	CcSEcCtD
Tolcapone—Paraesthesia—Epirubicin—ovarian cancer	0.000318	0.000348	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000317	0.000347	CcSEcCtD
Tolcapone—Dyspnoea—Epirubicin—ovarian cancer	0.000316	0.000346	CcSEcCtD
Tolcapone—Somnolence—Epirubicin—ovarian cancer	0.000315	0.000345	CcSEcCtD
Tolcapone—Anorexia—Doxorubicin—ovarian cancer	0.000312	0.000342	CcSEcCtD
Tolcapone—Nausea—Docetaxel—ovarian cancer	0.000312	0.000341	CcSEcCtD
Tolcapone—Dyspepsia—Epirubicin—ovarian cancer	0.000312	0.000341	CcSEcCtD
Tolcapone—Decreased appetite—Epirubicin—ovarian cancer	0.000308	0.000337	CcSEcCtD
Tolcapone—Hypotension—Doxorubicin—ovarian cancer	0.000306	0.000335	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000306	0.000335	CcSEcCtD
Tolcapone—Fatigue—Epirubicin—ovarian cancer	0.000305	0.000334	CcSEcCtD
Tolcapone—Pain—Epirubicin—ovarian cancer	0.000303	0.000331	CcSEcCtD
Tolcapone—Constipation—Epirubicin—ovarian cancer	0.000303	0.000331	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000299	0.000327	CcSEcCtD
Tolcapone—Paraesthesia—Doxorubicin—ovarian cancer	0.000294	0.000322	CcSEcCtD
Tolcapone—Dyspnoea—Doxorubicin—ovarian cancer	0.000292	0.00032	CcSEcCtD
Tolcapone—Feeling abnormal—Epirubicin—ovarian cancer	0.000292	0.000319	CcSEcCtD
Tolcapone—Somnolence—Doxorubicin—ovarian cancer	0.000291	0.000319	CcSEcCtD
Tolcapone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00029	0.000317	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—ovarian cancer	0.000288	0.000316	CcSEcCtD
Tolcapone—Decreased appetite—Doxorubicin—ovarian cancer	0.000285	0.000312	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000283	0.00031	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—ovarian cancer	0.000283	0.000309	CcSEcCtD
Tolcapone—Urticaria—Epirubicin—ovarian cancer	0.000281	0.000308	CcSEcCtD
Tolcapone—Pain—Doxorubicin—ovarian cancer	0.00028	0.000307	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—ovarian cancer	0.00028	0.000307	CcSEcCtD
Tolcapone—Abdominal pain—Epirubicin—ovarian cancer	0.00028	0.000306	CcSEcCtD
Tolcapone—Body temperature increased—Epirubicin—ovarian cancer	0.00028	0.000306	CcSEcCtD
Tolcapone—Feeling abnormal—Doxorubicin—ovarian cancer	0.00027	0.000296	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000268	0.000293	CcSEcCtD
Tolcapone—Hypersensitivity—Epirubicin—ovarian cancer	0.000261	0.000286	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—ovarian cancer	0.00026	0.000285	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—ovarian cancer	0.000259	0.000283	CcSEcCtD
Tolcapone—Body temperature increased—Doxorubicin—ovarian cancer	0.000259	0.000283	CcSEcCtD
Tolcapone—Asthenia—Epirubicin—ovarian cancer	0.000254	0.000278	CcSEcCtD
Tolcapone—Pruritus—Epirubicin—ovarian cancer	0.000251	0.000274	CcSEcCtD
Tolcapone—Diarrhoea—Epirubicin—ovarian cancer	0.000242	0.000265	CcSEcCtD
Tolcapone—Hypersensitivity—Doxorubicin—ovarian cancer	0.000241	0.000264	CcSEcCtD
Tolcapone—Asthenia—Doxorubicin—ovarian cancer	0.000235	0.000257	CcSEcCtD
Tolcapone—Dizziness—Epirubicin—ovarian cancer	0.000234	0.000256	CcSEcCtD
Tolcapone—Pruritus—Doxorubicin—ovarian cancer	0.000232	0.000254	CcSEcCtD
Tolcapone—Vomiting—Epirubicin—ovarian cancer	0.000225	0.000246	CcSEcCtD
Tolcapone—Diarrhoea—Doxorubicin—ovarian cancer	0.000224	0.000245	CcSEcCtD
Tolcapone—Rash—Epirubicin—ovarian cancer	0.000223	0.000244	CcSEcCtD
Tolcapone—Dermatitis—Epirubicin—ovarian cancer	0.000223	0.000244	CcSEcCtD
Tolcapone—Headache—Epirubicin—ovarian cancer	0.000222	0.000243	CcSEcCtD
Tolcapone—Dizziness—Doxorubicin—ovarian cancer	0.000217	0.000237	CcSEcCtD
Tolcapone—Nausea—Epirubicin—ovarian cancer	0.00021	0.00023	CcSEcCtD
Tolcapone—Vomiting—Doxorubicin—ovarian cancer	0.000208	0.000228	CcSEcCtD
Tolcapone—Rash—Doxorubicin—ovarian cancer	0.000207	0.000226	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—ovarian cancer	0.000206	0.000226	CcSEcCtD
Tolcapone—Headache—Doxorubicin—ovarian cancer	0.000205	0.000225	CcSEcCtD
Tolcapone—Nausea—Doxorubicin—ovarian cancer	0.000195	0.000213	CcSEcCtD
